
One less weight. Qualified for the Australian Open quarter-finals, where she is aiming for a first title, Iga Swiatek received additional good news on Monday. Unlike the Jannik Sinner case, the World Anti-Doping Agency (WADA) has confirmed that it will not appeal the positive control of Polish trimetazidine in August 2024. The five-time Grand Slam winner, who was suspended for a month last fall, is thus freed from the sword of Damocles that hung over her. Her version has succeeded in convincing the authorities. "Tests showed that the melatonin I had been using for a long time had been contaminated during manufacturing", she explained in November, justifying the use of this medication by her difficulty sleeping due to repeated travel, jet lag and stress. "WADA's scientific experts have confirmed that the specific scenario of contaminated melatonin, as presented by the athlete and accepted by the ITIA, is plausible and that there is no no scientific reasons to dispute it before the CAS, the agency's statement said. In addition, WADA sought the advice of external legal counsel, who found that the athlete's explanation for contamination was well supported, that the ITIA's decision was consistent with the World Anti-Doping Code and that there was no no reasonable basis for appeal of this decision before the CAS. » The world number 2 can now concentrate on the court: after four victories without dropping a single set, she will play her quarter-final against the American Emma Navarro on Wednesday in Melbourne.